FDA Approves Merck’s Keytruda® for Previously Treated Patients with Recurrent or Metastatic Cervical Cancer Whose Tumors Express PD-L1

The US Food and Drug Administration FDA has approved Keytruda pembrolizumab for the treatment of patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy whose tumors express PD-L1 Keytruda is the first Anti- [...]

Questions to Ask Before Radiation Therapy for the Treatment of Cervical Cancer

Radiation therapy or radiotherapy is a common way to treat cervical cancer Doctors who specialize in treating cancers with radiation are known as radiation oncologists During radiation therapy high-energy x-rays are used to kill cancer cells Radiation the [...]